We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$586B
AUM Growth
-$76.8B
Cap. Flow
-$24.4B
Cap. Flow %
-4.16%
Top 10 Hldgs %
27.57%
Holding
13,842
New
1,775
Increased
5,712
Reduced
4,842
Closed
1,483

Sector Composition

Rank Sector Weight
1 Technology 1.55%
2 Consumer Discretionary 0.95%
3 Financials 0.77%
4 Healthcare 0.67%
5 Industrials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRT
12601
Cross Timbers Royalty Trust
CRT
$63.7M
-18,419
Closed -$182K
CRWS icon
12602
Crown Crafts
CRWS
$32.1M
-14,108
Closed -$63.2K
CSMD icon
12603
Congress SMid Growth ETF
CSMD
$481M
-8,700
Closed -$260K
CSTL icon
12604
CALL
Castle Biosciences
CSTL
$1.02B
-31,100
Closed -$829K
CSTL icon
12605
PUT
Castle Biosciences
CSTL
$1.02B
-9,500
Closed -$253K
CTEX icon
12606
ProShares S&P Kensho Cleantech ETF
CTEX
$4.91M
-13,270
Closed -$285K
CTLP
12607
CALL
DELISTED
Cantaloupe
CTLP
-18,000
Closed -$171K
CTLP
12608
PUT
DELISTED
Cantaloupe
CTLP
-38,100
Closed -$362K
CTRN icon
12609
CALL
Citi Trends
CTRN
$619M
-19,100
Closed -$501K
CTRN icon
12610
Citi Trends
CTRN
$619M
-9,099
Closed -$225K
CTXR icon
12611
CALL
Citius Pharmaceuticals
CTXR
$15.8M
-53,800
Closed -$215K
CUBE icon
12612
CubeSmart
CUBE
$9.21B
-12,108
Closed -$506K
CUE icon
12613
CALL
Cue Biopharma
CUE
$168M
-373
Closed -$12.2K
CUE icon
12614
Cue Biopharma
CUE
$168M
-442
Closed -$14.5K
CUK
12615
CALL
DELISTED
Carnival PLC
CUK
-14,400
Closed -$324K
CURV icon
12616
PUT
Torrid Holdings
CURV
$215M
-71,400
Closed -$373K
CVGW
12617
PUT
DELISTED
Calavo Growers
CVGW
-128,200
Closed -$3.27M
CVEO icon
12618
Civeo
CVEO
$348M
-10,267
Closed -$233K
CVU icon
12619
PUT
CPI Aerostructures
CVU
$71.2M
-22,600
Closed -$91.5K
CWB icon
12620
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.61B
-4,435
Closed -$350K
CWEN.A
12621
PUT
DELISTED
Clearway Energy Class A
CWEN.A
-10,400
Closed -$254K
CWK icon
12622
PUT
Cushman & Wakefield Ltd
CWK
$3.44B
-29,600
Closed -$387K
CWS icon
12623
AdvisorShares Focused Equity ETF
CWS
$134M
-3,960
Closed -$256K
CXAI icon
12624
CALL
CXApp
CXAI
$9.12M
-1,480
Closed -$135K
CXAI icon
12625
PUT
CXApp
CXAI
$9.12M
-1,330
Closed -$121K

Similar funds

Jeff Yass's Q1 2025 Portfolio in Review

As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,483 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.

  • Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
  • Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
  • Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
  • Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
  • Jeff Yass opened 1,775 new positions and closed 1,483 in Q1 2025.
  • Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.